Author, year | Study arms | Confirmed prognostic factors |
---|---|---|
Robak 2010 [16] | FCR vs FC | None |
Hallek 2010 [17] | FCR vs FC | Del(17p), B2M, WCC, unmutated IGHV |
Goede 2014 [15] | R-Chl vs Chl O-Chl vs Chl | None |
Chanan-khan 2016 [46] | IBR vs Placebo-BR | None |
Van Oers 2015 [51] | M-OFA vs OBS | None |
Hillmen 2015 [47] | O-Chl vs Chl | None |
Robak 2017 [42] | OFA + FC vs FC | None |
Greil 2016 [44] | MR vs OBS | None |
Dartigeas 2017 [45] | MR vs OBS | Unmutated IGHV |
Robak 2018 [43] | MR vs OBS | Del(17p), Del(11q), elevated B2M |
Woyach 2018 [14] | IR vs Ibr | Age, Del(17p), LDH |
Seymour 2018 [40] | VenR vs BR | None |
Moreno 2019 [48] | I-O vs O-Chl | None |
Fischer 2019 [49] | Ven-O vs O-Chl | None |
Shanafelt 2019 [39] | IR vs FCR | None |
Sharman 2020 [50] | Acala vs Chl-O | None |
Ghia 2020 [41] | Acala vs BR | None |